<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(6)</volume><submitter>Song J</submitter><journal>ACS medicinal chemistry letters</journal><pagination>450-3</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4025852</full_dataset_link><abstract>A series of 36 thiosemicarbazone analogues containing the thiochromanone molecular scaffold functionalized primarily at the C-6 position were prepared by chemical synthesis and evaluated as inhibitors of cathepsins L and B. The most promising inhibitors from this group are selective for cathepsin L and demonstrate IC50 values in the low nanomolar range. In nearly all cases, the thiochromanone sulfide analogues show superior inhibition of cathepsin L as compared to their corresponding thiochromanone sulfone derivatives. Without exception, the compounds evaluated were inactive (IC50 > 10000 nM) against cathepsin B. The most potent inhibitor (IC50 = 46 nM) of cathepsin L proved to be the 6,7-difluoro analogue 4. This small library of compounds significantly expands the structure-activity relationship known for small molecule, nonpeptidic inhibitors of cathepsin L.</abstract><repository>biostudies-other</repository><pmcid>PMC4025852</pmcid><data_source>Europe PMC</data_source><pubmed_authors>Bayeh L</pubmed_authors><pubmed_authors>Conner ES</pubmed_authors><pubmed_authors>Chavarria GE</pubmed_authors><pubmed_authors>Charlton-Sevcik AK</pubmed_authors><pubmed_authors>Kumar GD</pubmed_authors><pubmed_authors>Pinney KG</pubmed_authors><pubmed_authors>Jones LM</pubmed_authors><pubmed_authors>Trawick ML</pubmed_authors><pubmed_authors>Song J</pubmed_authors><pubmed_authors>Chaplin DJ</pubmed_authors><pubmed_authors>Chen SE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L.</name><description>A series of 36 thiosemicarbazone analogues containing the thiochromanone molecular scaffold functionalized primarily at the C-6 position were prepared by chemical synthesis and evaluated as inhibitors of cathepsins L and B. The most promising inhibitors from this group are selective for cathepsin L and demonstrate IC50 values in the low nanomolar range. In nearly all cases, the thiochromanone sulfide analogues show superior inhibition of cathepsin L as compared to their corresponding thiochromanone sulfone derivatives. Without exception, the compounds evaluated were inactive (IC50 > 10000 nM) against cathepsin B. The most potent inhibitor (IC50 = 46 nM) of cathepsin L proved to be the 6,7-difluoro analogue 4. This small library of compounds significantly expands the structure-activity relationship known for small molecule, nonpeptidic inhibitors of cathepsin L.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Jun</publication><modification>2019-03-27T01:28:30Z</modification><creation>2019-03-27T01:28:30Z</creation></dates><accession>S-EPMC4025852</accession><cross_references><pubmed>24900494</pubmed><doi>10.1021/ml200299g </doi></cross_references></HashMap>